AVA 2017/Phoenix, Arizona- (September 14, 2017) - Christie Medical Holdings, the leader in near infrared vein finding technology, will be exhibiting at the AVA 2017 Annual Scientific Meeting at the Phoenix Convention Center in Phoenix, Arizona September 16-19. On Monday September 18 between 7-8:30 a.m. attendees will have the opportunity to attend the “Reducing PIVC Complications and Guiding Clinicians: Technology and the 5Ps” symposium, co-presented by B. Braun Medical and Christie Medical Holdings.
Speaker Dr. Gregory Schears will deliver key concepts in understanding the challenges of difficult peripheral venous access for intravenous catheter placement as well as best practices for overcoming these obstacles. Participants will discover how near infrared (NIR) vein visualization can improve peripheral venous access, positively affecting the patient experience and clinical outcomes. Attendees will discuss how vascular access leaders can facilitate implementation of these practices throughout their healthcare facility to achieve improved care for all their patients. Participants may also earn continuing education credits through a clinical education grant provided by Christie.
“Christie is pleased to bring VeinViewer technology to the AVA 2017 Annual Scientific Meeting,” says George Pinho, president, Christie Medical Holdings. “Attendees will have the chance to learn how they, as vascular access leaders, can implement use of VeinViewer technology as a standard practice and improve vascular access and the overall patient experience - while lowering the cost of care.”
VeinViewer® technology will be on display at the Christie Medical Holdings booth No. 112, where attendees can see demonstrations of this leading vascular visualization technology. Using near infrared light to create a real-time digital image of patient veins on the skin, VeinViewer lets clinicians see peripheral veins up to 10mm deep and blood patterns up to 15mm deep while also locating valves and bifurcations to aid in determining the point of insertion. VeinViewer reduces the time needed for IV insertion, reduces the use of PICCs by up to 30 percent, and improves first stick success rates by up to 100 percent when placing an IV catheter.
To learn more about Christie vein finding devices: VeinViewer Vision2 and VeinViewer Flex please visit www.christiemed.com.
About Christie Medical Holdings, Inc.
Christie Medical Holdings Inc. is a global company based in Memphis, Tenn., that discovers, develops and commercializes medical technologies. The company’s market-leading product, VeinViewer, is manufactured in the USA. It is a mobile vascular imaging system that allows health care providers to clearly see accessible vasculature as a real time HD image, directly on the surface of the skin. Christie Medical Holdings Inc. is owned by Christie Digital Systems Inc., a global visual technologies company and a subsidiary of Ushio Inc., Japan (JP:6925). For more information on Christie Digital Systems or Christie Medical Holdings, visit www.christiemed.com.
For cautions associated to Christie Medical Holdings products, please visit www.christiemed.com/cautions.